Foundation Medicine (Cambridge, MA) a development-stage diagnostic company focused on cancer genome analysis, closed a $16M Series A financing, bringing the total round to $33.5M. Participants include Kleiner Perkins Caufield & Byers, Google Ventures and Third Rock Ventures.

Awarepoint (San Diego, CA) a commercial-stage hospital data analysis and automation software suite focused on real-time patient care progression, closed a $27M Series F financing. Participants include Kleiner Perkins, Top Tier Capital Partners, Cardinal Partners, Venrock and Jafco Ventures. Thanx for your patience as we catch-up.

Siluria Technologies (San Francisco, CA) a development-stage biofuels company focused on methane conversion, closed a $20M Series B financing. Participants include Wellcome Trust, Alloy Ventures, Arch Venture Partners, Kleiner Perkins, Altitude Life Science Ventures, Lux Capital and Presidio Ventures.

Teladoc (Dallas, TX) a commercial-stage on-demand telehealth services provider, closed a $18.6M Series D financing. Participants include Kleiner Perkins, Cardinal Partners, HLM Venture Partners, Trident Capital and New Capital Partners.

iPierian (San Francisco, CA) a development-stage induced pluripotent stem cell (iPSC) drug discovery company focused upon neurodegenerative disease including ALS and Parkinson’s, closed a $6M Series B financing, bring the round total to $28M. Participants include SR One, Biogen Idec, Google Ventures, Mitsubishi UFJ Capital, ATEL Ventures, MPM Capital, Highland Capital Partners and Kleiner Perkins [...]

Pacific Biosciences (Menlo Park, CA) developer of single molecule real-time nucleic acid and protein sequencing system closed a $50M Series F financing. Participants include Gen-Probe, Monsanto, the Wellcome Trust, Sutter Hill Ventures, Deerfield Management, Intel Capital, Morgan Stanley, Redmile Group, T. Rowe Price, Mohr Davidow Ventures, Kleiner Perkins Caufield and Byers, Alloy Ventures, Maverick Capital, [...]

Veracyte (San Francisco, CA) a clinical-stage molecular diagnostics company focused on non-small cell lung cancer and thyroid cancers, closed a $28M Series B financing. Participants include Domain Associates, Kleiner Perkins Caufield & Byers, TPG Biotech and Versant Ventures.

Breathe Technologies (San Ramon, CA) a commercial-stage medical device company focused on therapeutic respiratory systems for the treatment of COPD and sleep apnea, closed a $23M Series C financing. Participants include DAG Ventures, Kleiner Perkins Caufield & Byers, Delphi Ventures, Synergy Ventures and Johnson & Johnson Development Corp..

CardioDx (Palo Alto, CA) a commercial-stage cardiovascular molecular diagnostics company focused on coronary artery disease, cardiac arrhythmia and heart failure, closed a $5M Series D financing, bring the total round to $34.5M. Participants include GE Healthymagination Fund, Kleiner Perkins Caufield & Byers, TPG Biotech, Intel Capital, Mohr Davidow Ventures, DAG Ventures, Pappas Ventures and Asset [...]

EdenIQ (Visalia, CA) a commercial-stage biofuel company focused on lignocellulosic material to boost ethanol yields from corn and sugarcane, closed a $12.4M Series B financing. Participants include Draper Fisher Jurvetson, Westly Group, Kleiner Perkins Caufield & Byers, Cyrus Capital Partners, Angeleno Group, Element Partners, Morgan Stanley, Advanced Equities, Omninet and Nimes Capital.

Juvaris BioTherapeutics (Burlingame, CA) a clinical-stage biopharma company focused on adjuvanted vaccines for seasonal flu and immunotherapeutics for Leukemia and animal health, closed a $12.5M Series B financing, bringing the total round to $25M. Participants include Kleiner Perkins Caufield & Byers, SV Life Sciences and an undisclosed corporate partner.

TransMedics (Andover, MA) a clinical-stage medical device company focused on a technology platform to maintain donor organs in near-physiologic and functioning condition during transport for organ transplantation, closed a $36M Series E financing. Participants include Foundation Capital, Kleiner Perkins Caufield & Byers, Flagship Ventures, 3i Group, Tudor Investment, VantagePoint Venture Partners, Sherbrooke Partners, Alta Partners, [...]

Nodality (San Francisco, CA) a development-stage molecular diagnostics company focused on hematological malignancies and autoimmune disorders, closed a $15.5M Series D financing. Participants include Pfizer Venture Investments, Laboratory Corp of America Holdings, Kleiner Perkins Caufield & Byers, Maverick Capital and TPG Growth.